Skip to main content

Jameson Buck

Equibles does not estimate personal net worth.

About Jameson Buck

Jameson Buck has spoken on 1 earnings call across 1 company, most recently for Astrazeneca PLC on February 10, 2026. The companies whose calls Jameson Buck spoke on are classified in the Healthcare sector.

Jameson Buck on recent calls

“One of the phase three readouts in the first half is azimuthase alpha, which I think had been batched as a three to five billion opportunity. But I'm aware there's three different trials.”
Analyst, Astrazeneca PLC Q4 FY2025 Earnings Call ·

Company network

Recent activity